Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q2 2023 Earnings Call Transcript August 14, 2023
Brainstorm Cell Therapeutics Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were $0.15.
Operator: Greetings, and welcome to the Brainstorm Cell Therapeutics Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. As a reminder this call is being recorded. And I’d now like to introduce your host for today’s call, Mr. Michael Wood...
